A brief review on how best to identify, delay, or avoid brain metastases in patients diagnosed with metastatic HER2+ breast cancer.
Data Show Guideline-Concordant Care Gaps in Inflammatory Breast Cancer
Timely guideline-concordant care may mitigate racial and ethnic disparities in overall survival among patients with inflammatory breast cancer.
SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care
Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD discuss findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024.
The Rapid Evolution of Cardiotoxicity in Breast Cancer and Why More Data is Needed
Despite a relatively small, though increasing, level of focus in oncology, radiation-induced heart damage in breast cancer is a relevant clinical problem that needs more attention.
Reducing Post-Mastectomy Disparities in Breast Cancer Minority Populations
A study evaluating disparities in breast reconstructive surgery sought to assess the impact of culture, race, and ethnicity in minority groups.
Genomic Assay Yields Strong Predictive Accuracy in HER2+ Breast Cancer
The test led to a modification in treatment plan for 48.1% of those with stage I to III HER2-positive breast cancer, 73.5% of which were reductions.
Preoperative Breast MRI Does Not Improve Surgical Plan/Local Control
Breast MRI in patients with newly diagnosed breast cancer increased mastectomy rates and biopsy needs.